Olanzapine for Chemotherapy-induced Nausea and Vomiting Prophylaxis

NCT04232423 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

90

Enrollment

OTHER_GOV

Sponsor class

Conditions

Complete Response Rate to Chemotherapy-induced Nausea and Vomiting Prophylaxis

Interventions

DRUG: Olanzapine 10 Mg ORAL TABLET
DRUG: Olanzapine 5 Mg ORAL TABLET
DRUG: Placebo ORAL TABLET

Sponsor

Department of Medical Services Ministry of Public Health of Thailand